Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: August 2013

Chapter 28 - Malignant germ cell tumors and sex cord-stromal tumors in adults and children

Related content

Powered by UNSILO


1. Patterson DM, Rustin GJ. Controversies in the management of germ cell tumours of the ovary. Curr Opin Oncol. 2006;18:500–6.
2. Smith HO, Berwick M, Verschraegen CF, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107:1075–85.
3. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25:2938–43.
4. Chan JK, Tewari KS, Waller S, et al. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008;98:111–6.
5. Bryant CS, Kumar S, Shah JP, et al. Racial disparities in survival among patients with germ cell tumors of the ovary – United States. Gynecol Oncol. 2009;114:437–41.
6. Giambartolomei C, Mueller CM, Greene MH, Korde LA. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol. 2009;33:31–6.
7. Jonson AL, Geller MA, Dickson EL. Gonadal dysgenesis and gynecologic cancer. Obstet Gynecol. 2010;116(Suppl 2):550–2.
8. Crum C. The female genital tract. In: Kumar V, Abbas AK, Fausto N (Eds.). Robbins and Cotran Pathologic Basis of Disease, 4th edition. Philadelphia: Elsevier; 2005.
9. Vaysse C, Delsol M, Carfagna L, et al. Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases. J Pediatr Surg. 2010;45:1484–90.
10. Alotaibi MOS, Navarro OM. Imaging of ovarian teratomas in children: a 9-year review. Can Assoc Radiol J. 2010;61:23–8.
11. Network NCC. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer In: Network NCC, ed. Vol 2.2012: (accessed February 14, 2012).
12. Sturgeon CM, Duffy MJ, Stenman U-H, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem. 2008;54:e11–79.
13. Ueland F, DeSimone C, Seamon L, et al. The OVA 1 test improves the preoperative assessment of ovarian tumors. Gynecol Oncol. 2010;116(Suppl):S23.
14. Weinberg LE, Lurain JR, Singh DK, Schink JC. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol. 2011;121:285–9.
15. Beiner ME, Gotlieb WH, Korach Y, et al. Cystectomy for immature teratoma of the ovary. Gynecol Oncol. 2004;93:381–4.
16. Kumar S, Shah JP, Bryant CS, et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110:125–32.
17. Mahdi H, Swensen RE, Hanna R, et al. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer. 2011;105:493–7.
18. Palenzuela G, Martin E, Meunier A, et al. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary. Ann Surg. 2008;248:836–41.
19. Billmire D, Vinocur C, Rescorla F, et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39:424–9.
20. Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18:43–50.
21. Cushing B, Giller R, Ablin A, et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children’s cancer group. Am J Obstet Gynecol. 1999;181:353–8.
22. Marina NM, Cushing B, Giller R, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol. 1999;17:2137–43.
23. Gobel U, Schneider DT, Calaminus G, et al. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol. 2000;11:263–71.
24. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev. 2008;34:427–41.
25. Murugaesu N, Schmid P, Dancey G, et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol. 2006;24:4862–6.
26. de La Motte Rouge T, Pautier P, Duvillard P, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol. 2008;19:1435–41.
27. Shah JP, Kumar S, Bryant CS, et al. A population-based analysis of 788 cases of yolk sac tumors: a comparison of males and females. Int J Cancer. 2008;123:2671–5.
28. Lai CH, Chang TC, Hsueh S, et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol. 2005;96:784–91.
29. Gershenson DM, Miller AM, Champion VL, et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:2792–7.
30. Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003;101:251–7.
31. Champion V, Williams SD, Miller A, et al. Quality of life in long-term survivors of ovarian germ cell tumors: A Gynecologic Oncology Group Study. Gynecol Oncol. 2007;105:687–94.
32. Matei D, Miller AM, Monahan P, et al. Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27:4142–9.
33. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
34. World Health Organization. International Histologic Classification of Tumors, No. 9. Geneva: World Health Organization; 1973.
35. Koonings PP, Campbell K, Mishell DR Jr, et al. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol. 1989;74:921–6.
36. Brown J, Olson T, Sencer S. Malignancies of the ovary. In: Bleyer WA, Barr RD (Eds.). Cancer in Adolescents and Young Adults. New York: Springer; 2007. p 219–36.
37. Bjorkholm E, Silfversward C. Granulosa and theca cell tumors: incidence and occurrence of second primary tumors. Acta Radiol Oncol. 1980;19:161.
38. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180–9.
39. Schultz KA, Sencer SF, Messinger Y, et al. Pediatric ovarian tumors: a review of 67 cases. Pediatr Blood Cancer. 2005;44:167–73.
40. Schneider DR, Calaminus G, Harms D, et al. Ovarian sex cord-stromal tumors in children and adolescents. J Reprod Med. 2005;50:439–46.
41. Gribbon M, Ein SH, Mancer K. Pediatric malignant ovarian tumors: a 43-year review. J Pediatr Surg. 1992;27:480.
42. Zaloudek C, Norris HJ. Sertoli-Leydig tumors of the ovary: a clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol. 1984;8:405.
43. Gershenson DM. Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monographs. 2005;34:43–7.
44. Srivasta PJ, Keeney GL, Podratz KC. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz–Jeghers syndrome. Gynecol Oncol. 1994;53:256.
45. Nosov V, Park S, Rao J, et al. Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report. Fertil Steril. 2009;92:1497.
46. Anderson MC, Rees DA. Gynandroblastoma of the ovary. Br J Obstet Gynecol. 1975;82:68.
47. Stevens TA, Brown J, Zander DS, et al. Adult granulosa cell tumors of the ovary in two first-degree relatives. Gynecol Oncol. 2005;98:502–25.
48. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;360:2719–29.
49. Heravi-Moussavi A, Anglesio MS, Cheng SW, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366:234–42.
50. Young RH, Scully RE. Endocrine tumors of the ovary. Curr Top Pathol. 1992;85:113–64.
51. Brown J, Jhingran A, Deavers M, et al. Stromal tumors of the ovary. In: Raghaven D, Brecher ML, Johnson DH, et al. (Eds.). Textbook of Uncommon Cancer. West Sussex, UK: John Wiley and Sons; 2006.
52. Roth LM, Anderson MC, Govan DT, et al. Sertoli-Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer. 1981;48:187.
53. Tao X, Sood AK, Deavers MT, et al. Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol. 2009;114:431–6.
54. McCluggage WG, Maxwell P, Sloan JM. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol. 1997;28:1034–8.
55. Zhao C, Barner R, Vinh TN, et al. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor. Int J Gynecol Pathol. 2008;27:507–14.
56. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. Am J Surg Pathol. 1984;8:575.
57. Gershenson DM, Hartmann LC, Young RH. Ovarian sex cord-stromal tumors. In: Hoskins WJ, Perez CA, Young RC (Eds.). Principles and Practice of Gynecologic Oncology, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
58. Van Holsbeke C, Domali E, Holland TK. Imaging of gynecological disease: clinical and ultrasound characteristics of granulosa cell tumors of the ovary. Ultrasound Obstet Gynecol. 2008;31:450–6.
59. Jung SE, Rha SE, Lee JM, et al. CT and MRI findings of sex cord-stromal tumor of the ovary. AJR Am J Roentgenol. 2005;185:207–15.
60. Mettler L, Semm K, Shive K. Endoscopic management of adnexal masses. J Soc Laparosc Surg. 1997;2:103–12.
61. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM. Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted? Gynecol Oncol. 2009;113:86–90.
62. Colombo N, Sessa C, Landoni F, et al. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol. 1986;37:265–8.
63. Gershenson DM, Morris M, Burke TW, et al. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996;87:527–31.
64. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination chemotherapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131–7.
65. Brown J, Shvartsman HS, Deavers MT, et al. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005;97:489–96.
66. Savage P, Constenla D, Fisher C, et al. Granulosa cell tumors of the ovary: demographics, survival, and the management of advanced disease. Clin Oncol (R Coll Radiol). 1998;10:242–5.
67. Brown J, Shvartsman HS, Deavers MT, et al. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004;22:3517–23.
68. Powell JL, Connor GP, Henderson GS. Management of recurrent juvenile granulosa cell tumor of the ovary. Gynecol Oncol. 2001;81:113–6.
69. Martikainen H, Penttinen J, Huhtaniemi I, et al. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy. Gynecol Oncol. 1989;35:406.